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hydrolysis, the intracellular fluorescein con-
centration in stimulated lymphocytes is
lower than in controls when the combined
effects of decreased rate of hydrolysis and
increased leakage are considered. It follows
that decreases in P of 10-50% after PHA or
tumour-antigen stimulations, as observed
in the SCM measurements (Cercek et al.,
1974; Cercek & Cereek, 1975, 1976, 1977,
1978a, b; Takaku et al., 1977; Nishifuku etal.,
1977; Hashimoto et al., 1978, 1979, Kreutz-
mann et al., 1978; Pritchard & Sutherland,
1978; Pritchard et al., 1978; Stewart et al.,
1979; Orjasaeter et al., 1979) cannot be
caused simply by increases in intracellular
.'fluorescein concentrations.
In conclusion, theinability ofBalding et al.
to repeat the SCM test cannot be accounted
for, as they suggest, by their rigid control
of the intracellular concentrations of fluore-
scein, but is explained adequately by their
insufficient attention to details of the SCM
protocol. The importance of the latter for
the success of the SCM test has been stressed
in all publications from the groups that have
successfully established the technique.
L. CERCEK
Pater,3on Laboratories,
Christie Hospital and
Holt Radiwnt Institute,
Withington, Manchester
J. A. V. PRITCHARD
W. H. SUTHERLAND
Tenovu8 Laboratories,
South Wales Radiotherapy and
0,)icology Service, Velindre Hospital,
Whitchurch, Cardiff
SIR,-Whilst ackno-,N,Iedging the disagree-
ment in interpretation between us and Dr
Cercek, -%Ne cannot accept some of the
generalizations presented in his letter.
The assertion that an asymptotic decrease
in P value is diagnostic ofstray-light artifact
is begging the question, and assumes a
linear relationship between P, duration of
hydrolysis and intracellular fluorescent in-
tensity (Fi). Udkoff & Norman (1979) quoted
in support in the letter, present a model that
agrees ii-ith our results, in that they predict
and demonstrate that P varies with Fi,
showing greater variance at lower intensities,
i.e. the relationship is "asymptotic". That
1-ie quotes Udkoff & Norman is all the more
14*
surprising in view of the latters' reference
to the Cerceks-quote (p. 54): "What
remains puzzling is that the Cerceks, with all
their publications on the effects of various
conditions on P, have not found the obvious
dependence of P on I.
"
The results presented by Epstein et al.
(1977) are for mouse EL4 leukaemia cells
and -%Aould therefore be relevant in a qualita-
tive and not quantitative sense. We obtain a
change in P of 0-6%/min. for mouse NK/ lymphoma (unpublished) and report in our
paper an 18% change in P for 400% increase
in Fi, not too different from the 16% change in P over the same range for EL4 cells
examined by Epstein et al. Dr Cercek now
reports a 10% decrease in P in human
lymphocytes for the same fluorescencechange using 2-5.um FDA.
All this is even more puzzling since the
dependence of P on Fi and the decrease in
P of 0-36%/min now presented by Dr
Cercek is in direct conflict with Cercek
et al. (1978 p. 398); quote: "Furthermore
the degree of polarization was the same
whether the measurements were made at
any time between 3 and 15 mins after the
cells were suspended in the FDA substrate
solution, i.e. the changes in bulk concentra-
tion of fluorescein from 6 x 10-10m to
3 x 10-9m had no effect on the polarization
spectra. Independence of the degree of
fluorescence polarization over a 10-fold
change in intracellular fluorescein concentra-
tion was also observed in fluorescence
polarization measurements ofsingle cells".
It is thus perplexing that these previously denied effects have now been so quantified
as to diagnose a problem ofstray light in our
spectrofluorimeter,particularly as that instru-
ment was used by Dr Cercek for his demon-
stration of SCM at the Charing Cross Work-
shop in November 1976 (Bagshawe, 1977) and judged by him to be satisfactory at
that time. That we were aware of possible stray-light problems may be judged from
the inclusion of a 505nm filter in the emission
light path (see Materials and Methods) as an
alternative to the simple expedient of
subtracting scatter values determined on
cell "blanks". Stray light has been quanti- fied at all times and, -%.,ith filter, judged as
not significant at the concentration of FDA
and cells used.
The reference to avoidance of pipetting
errors has nothing to do with stray light,LETTERS TO THE EDITOlR
since P is of course independent of cell con-
centration in the absence of strav light, but
concerns the need to measure hydrolysis
rates from bulk fluorescence levels, which will
certainly depend on cell concentration.
This would be essential if 80-90% of FSD
were to be used as an end point for P measure-
inent (Cercek & Cercek, 1977) since a varia-
tion in cell concentration will alter the total
F intensity, and cause a variation in P.
The comment about Cardiff is not accepted.
Our work there was illustrated by the one
example containing the highest number of
points. This w%as shown as representative of
the 6 patients and 4 healthy controls we
studied. The protocol "for successful and
consistent operation of the SCM test in
Cardiff" should have been established, since
before our use of their spectrofluorimeter
(i.e., Feb. 1977) results with the same appara-
tus were present in support of SCM at the
Charing Cross Workshop in November 1976.
The most recent technology advocated by
the Cerceks was used. The proposed publica-
tion of the results wa,as known to the head
of the Cardiff group in June 1979, before
acceptance of the paper (Sept., 1979).
We ere not aware that Drs Cercek or
Pritchard consistently measured B/T cell
ratios to make the assertion that their
preparations are 9000 pure lymphocytes
with 7500 T cells. Their methodology is
likely to produce a more heterogeneous
population (Currie et al., 1978; Hokland &
Heron, 1980) than that quoted, particularly
in cancer patients. We simply report our
observations.
The decision to use HEPES-buffered
Medium 199, rather than Wellcome TC199 as
reported by Cercek et al. (1974), was con-
sidered carefully, and comparisons made to
exclude prestimulation. In fact the much
greater pH stability of the HEPES-buffered
medium allowed us to avoid the pH-related
variation in fluorescent intensity (Visser
et al., 1979) which would have caused pH-
related variations in P. We question the
problem of impurities in acetone. This has
not been reported elsewhere, and-it seems to
us a remarkable coincidence that whereas we
obtain an "abrogated" response in healthy
donors, the lack of a differential would then
suggest, by that criterion, an "amplified"
response in cancer patients! We do not feel
that this explanation can fit both problems,
and further we would have to postulate
impurities in the acetic acid which wN,(e also
used.
Drs Cercek and Pritchard give the impres-
sion that 7 groups, in a number of publica-
tions, support their findings using both PHA
and CaBP on lymphocytes from normal
subjects and cancer patients. However,
Nishiffikcu et al. (1977) reports only the use
of PHA with normal subjects; Hashimoto et
al. 1979, used the `"wrong" equipment and the
"wrong" emission wavelength according to
the Cerceks (see Bagshawe, 1977, where the
importance of the spectral content ofthe lamp
wAas rated as important as the passband of
the monochromators); Orjaseter et al. (1979)
were unable to obtain a consistent differential
response using the Cerceks' techniques, but
found a differential response exhibited by
the sheep-cell-rosetting population only.
The statement that in their measurements
PHA always increases fluorescein leakage
and decreases hydrolysis rate is difficult to
accept on evidence presented to date. These
parameters could only have been determined
at fixed gain and dynode settings, or by the
use of an internal fluorescein standard.
Further, this is not supported by Mullen &
Campbell (1979) wvho use a significantly
different technique from that of the Cerceks.
We confirm that cells isolated on Ficoll-
Triosil (sp. gr. 1.077), washedandresuspended
in TC 199, often exhibit reduced FDA hydro-
lysis after PHA treatment. Mullen & Camp-
bell report a decrease in hydrolysis between
0 and 71% (mean 33%o) and a change in
leakage from +48.5% to -19-1%, but with
no significant difference in the mean.
However, pressure rather than the less
disruptive suction filtration was used (per-
sonal communication). They also found no
change in Km after PHA incubation, which
according to Cercek et al. (1973) would
produce no change in P either!
Finally, we comment that correct evalua-
tion of SCM as a test for malignancy re-
quires a rigidly controlled experimental
procedure (not as misquoted by Cercek and
Pritchard). Our paper was intended to
summarize the observation that in addition
to factors described in Materials and Methods,
due account must be given to factors such as
duration and rate of hydrolysis and leakiness
of cells. Further, special consideration needs
to be given to what exactly constitutes a
"blind" test of SCM
We do not feel that the SCM test as a test
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for malignant disease in the form so far
described is proven.
A. W. PREECE
P. A. LiGHT
P. BALDING
Oncology Research Unit,
Bristol Royal Infirmary
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